Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
06/2006
06/15/2006US20060128686 Preparation of pyridonecarboxylic acid antibacterials
06/15/2006US20060128669 3-(4-Fluorobenzyl)-8-hydroxy-quinoline-5,7-dicarboxylic acid 7-methylester; against Human T Cell leukemia virus, Feline and Simian immunodeficiency viruses, AIDS and related clinical symptoms
06/15/2006US20060128634 Alpha, alpha-disubstituted benzylglycine derivatives as HIV protease inhibitors
06/15/2006CA2589192A1 Phenyl-piperazin methanone derivatives
06/15/2006CA2587928A1 Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites
06/14/2006EP1669354A1 8-cyanoquinolonecarboxylic acid derivative
06/14/2006EP1668009A1 Hcv inhibitors and methods of using them
06/14/2006EP1667975A1 A polymorphic form of 3-phenylsulfonyl-8-piperazin-1-yl-quinoline
06/14/2006EP1667974A1 Process for producing high purity 3,5-dihydroxy-6-heptenoic acid derivative
06/14/2006EP1667973A2 Quinoline potassium channel inhibitors
06/14/2006EP1667683A2 Quinoline potassium channel inhibitors
06/14/2006EP1667675A1 Entry inhibitors of the hiv virus
06/14/2006EP1667647A2 Monocyclic and bicyclic lactams as factor xa inhibitors
06/14/2006EP1667635A2 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
06/14/2006CN1785977A 17-sulfonyl diversine and its preparation method
06/14/2006CN1785976A N-alkyl diversine and its preparation method
06/14/2006CN1785972A Premedicine acting on nervous centralis system
06/14/2006CN1259315C Antagonists of MCP-1 function and methods of use thereof
06/14/2006CN1259307C Acylated indanyl amines and their use as pharmaceuticals
06/13/2006US7060834 Using a 2-aminoquinoline compound
06/13/2006US7060832 Nitrogen-containing fused heterocyclic carboxylic acids having an absolute configuration of “R”
06/13/2006US7060712 Crystalline form of aryl aniline β2 adrenergic receptor agonist
06/13/2006US7060700 Amide derivatives useful as inhibitors of the production of cytokines
06/13/2006CA2131103C Pyrido[1,2,3-d,e][1,3,4]benzoxadiazine derivatives
06/08/2006WO2006060225A2 Process for asymmetric synthesis of hexahydropyrimido[1,2-a] azepine-2-carboxamides and related compounds
06/08/2006WO2006059945A1 Novel compounds
06/08/2006WO2006059781A1 Improved process for preparing rebamipide
06/08/2006WO2006059400A1 Antibiotics fki-2140, method of producing the same and strain producing the same
06/08/2006WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
06/08/2006WO2006059103A2 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products
06/08/2006WO2006058700A1 Acetamide compounds as fungicides
06/08/2006WO2006058699A1 1-alkynyl-2-aryloxyalkylamides and their use as fungicides
06/08/2006WO2006058545A1 New process for the preparation of a leukotriene antagonist
06/08/2006WO2006034512A3 Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes
06/08/2006WO2006023400A3 Chemical compounds
06/08/2006WO2006010095A3 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
06/08/2006US20060122390 Boronic ester and acid compounds, synthesis and uses
06/08/2006US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders
06/08/2006US20060122225 Asymmetric hydrogenation of enaminoesters without protecting the secondary amino group with a protective group; good asymmetric, chemical yields and workability; methyl (2R,4S)-(2-ethyl-6-trifluoromethyl-1,2,3,4-tetrahydroquinolin-4-yl)carbamate
06/08/2006US20060122224 Quinoline and quinoxaline compounds
06/08/2006US20060122223 Substituted amino carboxylic acids
06/08/2006US20060122193 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate
06/08/2006US20060122188 Anticoagulants; 2-[1S-(4-(ethoxycarbonyl)piperazin-1-yl)carbonyl-3-carboxypropyl]aminocarbonyl-4-(2-methylthiazol-4-yl)methoxyquinoline; antithrombotic agents in the treatment and prevention of thrombosis
06/08/2006DE102004044680B3 Alkyliden-Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate Alkylidene-tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories, as well as pharmaceutical compositions containing them
06/08/2006CA2589936A1 New process for the preparation of a leukotriene antagonist
06/08/2006CA2589639A1 8-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists
06/08/2006CA2589577A1 5-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists
06/08/2006CA2589010A1 Biaryloxymethylarene carboxylic acids
06/08/2006CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
06/08/2006CA2586334A1 Compounds for the treatment of cns and amyloid associated diseases
06/08/2006CA2583335A1 1-alkynyl-2-aryloxyalkylamides and their use as fungicides
06/07/2006EP1666466A2 Mutilin derivatives and their use as Antimicrobials
06/07/2006EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors
06/07/2006EP1664024A1 Synthesis of quinoline 5-carboxamides useful for the preparation of pde iv inhibitors
06/07/2006EP1663982A1 Aminoquinoline derivatives and their use as adenosine a3 ligands
06/07/2006EP1663981A1 Piperazinyl-quinoline derivatives useful for the treatment of cns disorders
06/07/2006EP1663980A1 Quinoline compounds and pharmaceutical compositions containing them
06/07/2006EP1663976A1 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents
06/07/2006EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
06/07/2006EP1663951A2 Process for the synthesis of 6-amino-4-¬(3-chloro-4-fluorophenyl)amino|-7-ethoxyquinoline-3-carbonitrile
06/07/2006EP1663234A1 Piperazine derivatives for the treatment of hiv infections
06/07/2006EP1663227A2 Dihydropyridine compounds for treating or preventing metabolic disorders
06/07/2006EP1663204A2 C-kit modulators and methods of use
06/07/2006EP1048694B1 Azo compounds and process for producing the same
06/07/2006CN1784395A Piperazine-alkyl-ureido derivatives
06/07/2006CN1784385A Process for the preparation of carbostyril derivatives, such as aripiprazole and its intermediates
06/07/2006CN1784384A Method for producing the purest rac-1-{4-(2-hydroxy-3-(5-quinolyloxy)propyl) piperazin-1-yl}-2,2-diphenylethan-1-one fumarate and the purest rac-1-{4-(2-hydroxy-3-(5-quinolyloxy)propyl)piperazin-1-yl}
06/07/2006CN1784380A Novel bioisosteres of actinonin
06/07/2006CN1784229A Heterocyclic kinase inhibitors: methods of use and synthesis
06/06/2006US7057048 Androgen receptor antagonists
06/06/2006US7056931 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
06/06/2006US7056923 Anticoagulants
06/06/2006US7056912 Heteroaryl derivatives and their use as medicaments
06/06/2006US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists
06/06/2006CA2215066C Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
06/01/2006WO2006058201A2 Heterocyclic and bicyclic compounds, compositions and methods
06/01/2006WO2006057460A1 Nitrogen-containing fused ring compound and use thereof
06/01/2006WO2006056696A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
06/01/2006WO2006014918A3 Heterocyclic acetophenone potentiators of metabotropic glutamate receptors
06/01/2006WO2005123684A3 Enantioselektive preparation of quinoline derivative
06/01/2006US20060116418 Materials and methods for treating hypercholesterolemia
06/01/2006US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
05/2006
05/31/2006EP1660503A1 Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents
05/31/2006EP1660483A1 8-(1-piperazinyl)-quinoline derivatives and their use in the treatment of cns disorders
05/31/2006EP1660481A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators
05/31/2006EP1660453A2 Process for the preparation of 4-amino-3-quinolinecarbonitriles
05/31/2006EP1660452A1 Quinoline derivatives as neutrophil elastase inhibitors and their use
05/31/2006EP1660431A2 Phenoxyacetic acid derivatives
05/31/2006EP1660427A1 Substituted arylalkanoic acid derivative and use thereof
05/31/2006EP1660087A2 Quinolinone derivatives as inhibitors of c-fms kinase
05/31/2006EP1556356B1 Tetrahydroquinoline derivatives as crth2 antagonists
05/31/2006EP1453512B1 Acetylene derivatives having mglur 5 antagonistic activity
05/31/2006EP1420644B1 Substituted propargylamines
05/31/2006EP1296967B1 Benzothiazolyl ppar-gamma modulators
05/31/2006EP1296931B1 Polyamine analogues as cytotoxic agents
05/31/2006EP1163238B1 Chemokine recpetor binding heterocyclic compounds
05/31/2006EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
05/31/2006CN1778800A Chiral piperazine substrated quinolone carboxylic acid derivative, and preparation and use thereof
05/31/2006CN1257901C Tetrahydroquinoline ketopiperidine compounds and their preparation and use
05/31/2006CN1257886C Dehydroamino acids compounds